NEA Management Company’s Epizyme, Inc EPZM Stock Holding History

NEA Management Company’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,377,518	Closed	-$67.9M	–	49
2020 Q1	$67.9M	Hold	4,377,518	–	–	3.55%	12
2019 Q4	$108M	Hold	4,377,518	–	–	5.09%	8
2019 Q3	$45.2M	Hold	4,377,518	–	–	3.74%	7
2019 Q2	$54.9M	Sell	4,377,518 -2,500,000	-36%	-$32.2M	3.85%	9
2019 Q1	$85.2M	Hold	6,877,518	–	–	4.42%	6
2018 Q4	$42.4M	Buy	6,877,518 +416,667	+6%	+$3.18M	1.68%	12
2018 Q3	$68.5M	Hold	6,460,851	–	–	2.96%	11
2018 Q2	$87.5M	Hold	6,460,851	–	–	4.1%	8
2018 Q1	$115M	Hold	6,460,851	–	–	5.1%	6
2017 Q4	$81.1M	Hold	6,460,851	–	–	3.36%	8
2017 Q3	$123M	Buy	6,460,851 +200,000	+3%	+$3.05M	4.31%	3
2017 Q2	$94.5M	Hold	6,260,851	–	–	3.44%	6
2017 Q1	$107M	Hold	6,260,851	–	–	3.73%	5
2016 Q4	$75.8M	Hold	6,260,851	–	–	3.01%	4
2016 Q3	$61.6M	Hold	6,260,851	–	–	2.77%	8
2016 Q2	$64.1M	Hold	6,260,851	–	–	3.33%	7
2016 Q1	$75.9M	Buy	6,260,851 +1,111,111	+22%	+$11.2M	5.04%	5
2015 Q4	$82.5M	Hold	5,149,740	–	–	5.25%	6
2015 Q3	$66.2M	Hold	5,149,740	–	–	4.36%	8
2015 Q2	$124M	Hold	5,149,740	–	–	6.45%	5
2015 Q1	$96.7M	Hold	5,149,740	–	–	4.37%	6
2014 Q4	$97.2M	Hold	5,149,740	–	–	4.71%	7
2014 Q3	$140M	Sell	5,149,740 -1,296,349	-20%	-$40.3M	7.1%	4
2014 Q2	$201M	Hold	6,446,089	–	–	9.41%	3
2014 Q1	$147M	Hold	6,446,089	–	–	7.21%	5
2013 Q4	$134M	Buy	6,446,089 +406,500	+7%	+$11.8M	6.48%	5
2013 Q3	$242M	Hold	6,039,589	–	–	9.57%	4
2013 Q2	$170M	Buy	+6,039,589	New	+$155M	7.59%	3

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

NEA Management Company's EPZM Position: Q2 2020 in Review

NEA Management Company sold out of Epizyme, Inc (EPZM) in Q2 2020, closing a stake of 4,377,518 shares — an estimated $67.9M sold.

NEA Management Company first reported a position in EPZM in Q2 2013 and held it in 28 quarters. The position peaked at $242M in Q3 2013. 160 funds tracked by Wall St. Rank hold EPZM as of Q2 2020.

NEA Management Company reported no remaining Epizyme, Inc position as of Q2 2020 after selling out during the quarter.
NEA Management Company sold 4,377,518 Epizyme, Inc shares in Q2 2020, an estimated $67.9M.
NEA Management Company first reported a position in Epizyme, Inc in Q2 2013 and held it in 28 quarters.
NEA Management Company's Epizyme, Inc position peaked at $242M in Q3 2013.
160 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2020.

Based on NEA Management Company's 13F filing for Q2 2020, filed 5 Aug 2020.